On October 31, 2024, PMC published a letter to the editor of The Wall Street Journal in response to an earlier article in the Journal titled "Cancer Care Is Getting Personal. Local Doctors Can’t Keep Up."

This opinion essay is designed to inform Inside Precision Medicine’s readers about the Coalition’s progress toward facilitating broader clinical adoption of personalized medicine during the past two years.

PMC President Edward Abrahams provides an update on the state of the Coalition two decades after its launch in 2004.

PMC Senior Vice President for Public Affairs Christopher J. Wells reflects on U.S. National Institutes of Health Director Monica Bertagnolli's keynote remarks at the 16th Annual State of Personalized Medicine Luncheon in Washington, DC.

This opinion essay was published on April 5, 2024, in The Boston Globe's healthcare affiliate, STAT.

Morehouse School of Medicine's Dr. James Lillard underlines the significance of new PMC findings outlining how researchers and policymakers can promote more diversity and inclusion in biomedical research.

PMC Senior Vice President for Public Policy Cynthia A. Bens introduces the Coalition's 2024 Policy Agenda.

PMC President Edward Abrahams and Board Chairman Lincoln Nadauld introduce the Coalition's 2023 - 2024 Impact Report.

PMC Senior Vice President for Public Affairs Christopher J. Wells previews the potential impact of the Coalition's 2024 public affairs programs.

PMC President Edward Abrahams shares the Coalition's Strategic Plan for Advancing Personalized Medicine in 2024.

PMC Senior Vice President for Public Affairs Christopher J. Wells summarizes the impact of the 17th Annual Personalized Medicine Conference.

PMC President Edward Abrahams responds to the August 6, 2023, article in The New York Times titled "Personalized Medicine’s False Promise."